nach oben

World Journal of Pediatrics

Erschienen in:

12.02.2020 | Meta-analysis

Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis

verfasst von: Yadollah Zahed Pasha, Shaghayegh Alizadeh-Tabari, Ermia Zahed Pasha, Mohammad Zamani

Erschienen in: World Journal of Pediatrics | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Jaundice is a life-threatening disorder in the neonates. In the present study, we aimed to assess systematically available evidence on causes and management of jaundice in Iranian newborn patients.

Methods

We searched the databases of PubMed, Web of Sciences, Scopus and Google Scholar for English articles published since inception until May 2019. A search was also done for Persian articles in Magiran and Scientific Information Database. Studies were evaluated based on predefined criteria by two reviewers. Data analysis was performed by STATA software.

Results

A total of 33 articles were finally included. The overall pooled prevalence of causes of jaundice among Iranian neonates was as follows: ABO blood groups incompatibility, 16.9% [95% confidence interval (CI) 10.9–22.8]; Rh blood group incompatibility, 4% (95% CI 2.5–5.5); ABO and Rh blood groups incompatibility, 3.6% (95% CI 0–7.7); glucose-6-phosphate dehydrogenase (G6PD) deficiency, 6.3% (95% CI 5.1–7.5); infection, 6.6% (95% CI 5.2–8.1); hypothyroidism, 4.2% (95% CI 0.1–8.3); infant of diabetic mother: 2.3% (95% CI 0.1–4.5); unknown, 50.7% (95% CI 33.4–68); cephalohematoma, 0.6% (95% CI 0.3–0.9). Regarding treatment of icterus, seven and eight articles were found on phototherapy and exchange transfusion, respectively. In five studies, all patients underwent phototherapy, but rate of exchange transfusion use was between 6.6% and 50.9%.

Conclusions

According to the results, unknown factors were the most common causes of icterus in Iranian neonates, followed by ABO blood groups incompatibility, infections and G6PD deficiency. By the way, phototherapy and exchange transfusion were found as therapeutic choices of neonatal jaundice.

Nur mit Berechtigung zugänglich

Olusanya BO, Ogunlesi TA, Kumar P, Boo NY, Iskander IF, de Almeida MF, et al. Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings. BMC Pediatr. 2015;15:39.PubMedPubMedCentral

Hossain M, Begum M, Ahmed S, Absar MN. Causes, management and immediate complications of management of neonatal jaundice─a hospital-based study. J Enam Med Col. 2015;5:104–9.

Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C, Tilford JM. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988–2005. Pediatrics. 2009;123:524–32.PubMed

Slusher TM, Zamora TG, Appiah D, Stanke JU, Strand MA, Lee BW, et al. Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatr Open. 2017;1:e000105.PubMedPubMedCentral

Olusanya BO, Osibanjo FB, Slusher TM. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PLoS One. 2015;10:e0117229.PubMedPubMedCentral

Mishra S, Agarwal R, Deorari AK, Paul VK. Jaundice in the newborns. Indian J Pediatr. 2008;75:157–63.PubMed

Olusanya BO, Teeple S, Kassebaum NJ. The contribution of neonatal jaundice to global child mortality: findings from the GBD 2016 study. Pediatrics. 2018;141:e20171471.PubMed

Schwartz HP, Haberman BE, Ruddy RM. Hyperbilirubinemia: current guidelines and emerging therapies. Pediatr Emerg Care. 2011;27:884–9.PubMed

Kuzniewicz MW, Wickremasinghe AC, Wu YW, McCulloch CE, Walsh EM, Wi S, et al. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics. 2014;134:504–9.PubMed

10.

Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in neonates: types, causes, clinical examinations, preventive measures and treatments: a narrative review article. Iran J Public Health. 2016;45:558–68.PubMedPubMedCentral

11.

Zabeen B, Nahar J, Nabi N, Baki A, Tayyeb S, Azad K, et al. Risk factors and outcome of neonatal jaundice in a tertiary hospital. Ibrahim Med Coll J. 2010;4:70–3.

12.

Boskabadi H, Zakerihamidi M, Bagheri F, Boskabadi A. Evaluation of the causes of neonatal jaundice, based on the infant’s age at disease onset and age at hospital admission. Tehran Univ Med J. 2016;73:724–31 (in Persian).

13.

Wan A, Mat Daud S, Teh SH, Choo YM, Kutty FM. Management of neonatal jaundice in primary care. Malays Fam Physician. 2016;11:16–9.PubMedPubMedCentral

14.

Ahmadpour-Kacho M, Zahed Pasha Y, Haghshenas M, Akbarian Rad Z, Firouzjahi A, Bijani A, et al. Cord blood alkaline phosphatase as an indicator of neonatal jaundice. Iran J Pediatr. 2015;25:e718.PubMedPubMedCentral

15.

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.

16.

Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934–9.PubMed

17.

Mahmodi Z, Mahmodi F. Epidemiology and risk factors for neonatal jaundice in infants admitted to NICU of Imam Sajjad Hospital. Yasooj. Avicenna J Clin Med. 2016;22:346–52 (in Persian).

18.

Akhavi-Rad S, Rafati S, Hajieh B, Zaeri F, Safabakhsh M. Evaluation of frequency of hypothyroidism in newborns with indirect hyperbilirubinemia. Daneshvar Med. 2007;14:1–4 (in Persian).

19.

Ghaemi S, Fesharaki RJ, Kelishadi R. Late onset jaundice and urinary tract infection in neonates. Indian J Pediatr. 2007;74:139–41.PubMed

20.

Marzban A, Mosavinasab N. Correlation between hemolysis and jaundice in glucose 6-phosphate dehydrogenase deficient neonates. Acta Medica Iranica. 2009;47:379–82.

21.

Najati N, Gharebaghi M, Mortazavi F. Underlying etiologies of prolonged icterus in neonates. Pak J Bio Sci. 2010;13:711–4.

22.

Pahlavanzadeh M, Hekmatimoghaddam S, Teremahi Ardestani M, Ghafoorzadeh M, Aminorraaya M. G6PD enzyme deficiency in neonatal pathologic hyperbilirubinemia in Yazd. Iran J Ped Hematol Oncol. 2013;3:69–72.PubMedPubMedCentral

23.

Saboute M, Mazouri A, Khalesi N, Hoseiny Nejad N, Razaghian A. The effect of intensive phototherapy on management of hyperbilirubinemia in neonates with the gestational age of 34 weeks and more. Iran J Neonatol. 2017;8:83–8.

24.

Hosseini S, Jalali R, Hosseini R, Masroor N, Abdifard E, Maleki-Jamasbi M, et al. Factors associated with urinary tract infection in neonates with prolonged jaundice admitted to neonatal intensive-care unit (NICU). J Isfahan Med Sch. 2015;33:1403–11.

25.

Ghotbi N, Sheikh-Ahmadi K. Epidemiology of pathologic neonatal jaundice in sanandaj in 1998. Scientific J Kurdistan Univ Med Sci. 2001;5:37–40 (in Persian).

26.

Javadi T, Mohsenzadeh A. Evaluation of the causes of jaundice in neonates admitted to Madani Hospital of Khorram Abad in 2002. Yafte. 2006;7:73–8.

27.

Fallahi M, Fatemeh Basir M, Ahmadipour GM. Evaluation of frequency of bacteremia in neonates with jaundice admitted in Shohadaye Tajrish Hospital. Pajoohandeh. 2009;14:27–30 (in Persian).

28.

Khosravi N, Aminian A, Taghipour R. Total serum magnesium level in icteric neonates before and after phototherapy. Tehran Univ Med J. 2011;69:432–7 (in Persian).

29.

Ahmadpour-Kacho M, Zahedpasha Y, Soleimani Rad H, Bijani A. Effect of phototherapy on serum magnesium level in term neonates with hyperbilirubinemia. Med J Mashhad Univ Med Sci. 2014;57:751–5 (in Persian).

30.

Mirfazeli A, Najafi L, Noohi AH, Cheraghali R. Etiologies of severe indirect hyperbilirubnemia in term neonates, Gorgan–Iran. J Gorgan Univ Med Sci. 2010;11:82–6 (in Persian).

31.

Aletayeb SMH, Dehdashtian M, Aramesh MR, Arash M, Hedayati Z, Taheri M. Outcome of Jaundice in neonates with ABO and Rh blood incompatibility and glucose-6-phosphate dehydrogenase deficiency. Biomed Res. 2017;28:3440–4.

32.

Behjati S, Sagheb S, Aryasepehr S, Yaghmai B. Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian J Pediatr. 2009;76:83–5.PubMed

33.

Hemmati F, Hashemi Z. Evaluation of the predictive value of umbilical cord serum bilirubin level for the development of subsequent hyperbilirubinemia in term and late-preterm neonates. Iran J Neonatol. 2016;7:25–31.

34.

Sabzehei MK, Basiri B, Gohari Z, Bazmamoun H. Etiologies of prolonged unconjugated hyperbilirubinemia in neonates admitted to neonatal wards. Iran J Neonatol. 2015;6:37–42.

35.

Koosha A, Rafizadeh B. Evaluation of neonatal indirect hyperbilirubinaemia at Zanjan Province of Iran in 2001–2003: prevalence of glucose-6-phosphate dehydrogenase deficiency. Singapore Med J. 2007;48:424–8.PubMed

36.

Sharif MR, Madani M. Evaluating the causes of prolonged jaundice among the newborns referred to Kashan Shahid-Beheshti hospital during 2011–2012. Feyz. 2014;18:91–6 (in Persian).

37.

Ghoreyshi SZ, Soltani Ahari H, Ghoreyshi S. Glucose-6-phosphate dehydrogenase deficiency in icteric neonates admitted in Tabriz pediatric medical center. Med J Tabriz Univ Med Sci Health Serv. 2007;29:89–93 (in Persian).

38.

Eghbalian F, Monsef AR. Evaluation of glucose-6-phosphate dehydrogenase deficiency without hemolysis in icteric newborns. Iran J Ped. 2007;17:36–40 (in Persian).

39.

Nobahar M, Vafaei A. Investigation of glucose-6-phosphate dehydrogenase deficiency by NADP test in jaundiced newborn. J Qazvin Univ Med Sci. 2004;29:46–51 (in Persian).

40.

Shiva F, Ghotbi F. Neonatal jaundice and necessity of evaluation of sepsis in icteric neonates. Res Med. 2002;26:111–4 (in Persian).

41.

Behjati-Ardakani S, Nikkhah A, Sedaghat M. The association between G6PD deficiency and total serum bilirubin level in icteric neonates. Acta Med Iran. 2007;45:233–5.

42.

Iranpour R, Akbar M, Haghshenas I. Glucose-6-phosphate dehydrogenase deficiency in neonates. Indian J Pediatr. 2003;70:855–7.PubMed

43.

Iranpour R, Hashemipour M, Talaei SM, Soroshnia M, Amini A. Newborn screening for glucose-6-phosphate dehydrogenase deficiency in Isfahan, Iran: a quantitative assay. J Med Screen. 2008;15:62–4.PubMed

44.

Mohammadzadeh A, Jafarzadeh M, Farhat AS, Keramati MR, Badiee Z, Esmaily HO, et al. Prevalence of glucose-6-phosphate dehydrogenase deficiency in neonates of Northeast of Iran. J Chin Clin Med. 2009;4:448–51.

45.

Najib KS, Saki F, Hemmati F, Inaloo S. Incidence, risk factors and causes of severe neonatal hyperbilirubinemia in the South of Iran (fars province). Iran Red Crescent Med J. 2013;15:260–3.PubMedPubMedCentral

46.

Abolghasemi H, Mehrani H, Amid A. An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates. Clin Biochem. 2004;37:241–4.PubMed

47.

Yousefi J, Mirzadeh M, Malek A. The role of hemolysis in inducing jaundice in the newborns with G6PD deficiency. Iran J Ped. 2006;16:462–6.

48.

Haji-Ebrahim-Tehrani F, Faghihzade S, Borna H. Evaluation of necessity of glucose-6-phosphate dehydrogenase (G6PD) in newborns with hyperbilirubinemia. Daneshvar Med. 2004;11:29–322 (in Persian).

49.

Khalesy N, Khosravi N, Haghighi M. Prevalence of glucose-6-phosphate dehydrogenase deficiency in neonates born in Tehran-Iran (2008–09). J Gorgan Univ Med Sci. 2012;14:100–5 (in Persian).

50.

Khodashenas E, Kalani-Moghaddam F, Araghi Z, Khodaparast M, Yazdani Z. Glucose-6-phosphate dehydrogenase deficiency and neonatal hyperbilirubinemia. Iran J Neonatol. 2015;6:28–31.

51.

Fakhraee S, Haji-Ebrahim-Tehrani F, Amid M, Kazemian M. Results of urine and blood cultures in healthy jaundiced newborns: making the correct choice. Arch Iranian Med. 2002;5:88–90.

52.

Zarkesh M, Safayi Assl A, Ramtinfar S, Shakiba M. Incidence of hyperbilirubinemia and urinary tract infection (UTI) in asymptomatic term neonates under two weeks of age. Iran J Neonatol. 2015;6:45–8.

53.

Pashapour N, Nikibahksh AA, Golmohammadlou S. Urinary tract infection in term neonates with prolonged jaundice. Urol J. 2007;4:91–4.PubMed

54.

Khalesi N, Shahraki T, Haghighi M. Prevalence of urinary tract infection in neonates with prolonged jaundice referred to Aliasghar Hospital in Zahedan (2005). J Qazvin Univ Med Sci. 2007;11:14–8.

55.

Firoozi H, Seidan Anbi S, Mousavi J, Farshidi F, Rezai MS. Prevalence of urinary tract infection in neonates with hyperbilirubinemia. J Mazandaran Univ Med Sci. 2019;28:91–7 (in Persian).

56.

Eghbalian F, Monsef AR. Prolonged jaundice as an early manifestation of asymptomatic urinary tract infection. J Urmia Univ Med Sci. 2009;20:98–103 (in Persian).

57.

Erdeve O, Okulu E, Olukman O, Ulubas D, Buyukkale G, Narter F, et al. The Turkish Neonatal Jaundice Online Registry: a national root cause analysis. PLoS One. 2018;13:e0193108.PubMedPubMedCentral

58.

Rasul CH, Hasan MA, Yasmin F. Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in Bangladesh. Malays J Med Sci. 2010;17:40–4.PubMedPubMedCentral

59.

Alkhotani A, Eldin EE, Zaghloul A, Mujahid S. Evaluation of neonatal jaundice in the Makkah region. Sci Rep. 2014;4:4802.PubMedPubMedCentral

60.

Shah A, Shah C, Shah V. Study of hematological parameters among neonates admitted with neonatal jaundice. J Evol Med Dent Sci. 2012;1:203–8.

61.

Henny-Harry C, Trotman H. Epidemiology of neonatal jaundice at the University Hospital of the West Indies. West Indian Med J. 2012;61:37–42.PubMed

62.

Lauer BJ, Spector ND. Hyperbilirubinemia in the newborn. Pediatr Rev. 2011;32:341–9.PubMed

63.

Drabik-Clary K, Reddy VV, Benjamin WH, Boctor FN. Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother. Ann Clin Lab Sci. 2006;36:205–7.PubMed

64.

Watchko JF. Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights. Pediatr Clin North Am. 2009;56:671–87.PubMed

65.

Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013;74(Suppl 1):86–100.PubMedPubMedCentral

66.

Sinha R, Sachendra B, Syed VS, Nair L, John B. To study the prevalence of glucose 6 phosphate dehydrogenase (G6PD) deficiency in neonates with neonatal hyperbilirubinemia and to compare the course of the neonatal jaundice in deficient versus non deficient neonates. J Clin Neonatol. 2017;6:71–4.

67.

Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175:587–90.PubMedPubMedCentral

68.

AlSaif S, Ponferrada MB, AlKhairy K, AlTawil K, Sallam A, Ahmed I, et al. Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples. BMC Pediatr. 2017;17:159.PubMedPubMedCentral

69.

Omar C, Hamza S, Bassem AM, Mariam R. Urinary tract infection and indirect hyperbilirubinemia in newborns. N Am J Med Sci. 2011;3:544–7.PubMedPubMedCentral

70.

Mutlu M, Çayır Y, Aslan Y. Urinary tract infections in neonates with jaundice in their first two weeks of life. World J Pediatr. 2014;10:164–7.PubMed

71.

Xinias I, Demertzidou V, Mavroudi A, Kollios K, Kardaras P, Papachristou F, et al. Bilirubin levels predict renal cortical changes in jaundiced neonates with urinary tract infection. World J Pediatr. 2009;5:42–5.PubMed

72.

Israel-Aina Y, Omoigberale A. Risk factors for neonatal jaundice in babies presenting at the University of Benin Teaching Hospital Benin City. Niger J Paed. 2012;39:159–63.

73.

Wong RJ, DeSandre GH, Sibley E, Stevenson DK. Neonatal jaundice and liver disease. In: Fanaroff AA, Martin RJ, Walsh MC, editors. Fanaroff and Martin’s neonatal-perinatal medicine : diseases of the fetus and infant. 8th ed. Philadelphia: Mosby Elsevier; 2006. p. 1419–66.

74.

Boskabadi H, Maamouri G, Mafinejad S. The effect of traditional remedies (Camel's Thorn, Flixweed and Sugar Water) on idiopathic neonatal jaundice. Iran J Pediatr. 2011;21:325–30.PubMedPubMedCentral

75.

Bratlid D, Nakstad B, Hansen TW. National guidelines for treatment of jaundice in the newborn. Acta Paediatr. 2011;100:499–505.PubMed

76.

Opara PI, Jaja T, Onubogu UC. Morbidity and mortality amongst infants of diabetic mothers admitted into a special care baby unit in Port Harcourt. Nigeria. Ital J Pediatr. 2010;36:77.PubMed

77.

Gleason CA, Devaskar S. Avery's diseases of the newborn. 9th ed. Philadelphia: Saunders Elsevier; 2011.

78.

Ives NK. Management of neonatal jaundice. Paediatr Child Health. 2011;21:270–6.

79.

Xiong T, Qu Y, Cambier S, Mu D. The side effects of phototherapy for neonatal jaundice: what do we know? What should we do? Eur J Pediatr. 2011;170:1247–55.PubMed

80.

Muchowski KE. Evaluation and treatment of neonatal hyperbilirubinemia. Am Fam Physician. 2014;89:873–8.PubMed

81.

Maisels M, Watchko J, Bhutani V, Stevenson D. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 2012;32:660–4.PubMed

82.

Edris AA, Ghany EA, Razek AR, Zahran AM. The role of intensive phototherapy in decreasing the need for exchange transfusion in neonatal jaundice. J Pak Med Assoc. 2014;64:5–8.PubMed

Titel: Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis
verfasst von: Yadollah Zahed Pasha
Shaghayegh Alizadeh-Tabari
Ermia Zahed Pasha
Mohammad Zamani
Publikationsdatum: 12.02.2020
Verlag: Springer Singapore
Erschienen in: World Journal of Pediatrics / Ausgabe 5/2020
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI: https://doi.org/10.1007/s12519-020-00339-3

Neu im Fachgebiet Pädiatrie

23.04.2024 | Typ-1-Diabetes | Nachrichten

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Acute infectious osteomyelitis in children: new treatment strategies for an old enemy

Psychological interventions for adherence, metabolic control, and coping with stress in adolescents with type 1 diabetes: a systematic review

Childhood obesity, cardiovascular and liver health: a growing epidemic with age

Global Pediatric Pulmonology Alliance recommendation to strengthen prevention of pediatric seasonal influenza under COVID-19 pandemic

Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?

Joy of gardening: a hospital-based cooking and gardening program

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie